1. Home
  2. NX vs AURA Comparison

NX vs AURA Comparison

Compare NX & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$19.85

Market Cap

819.4M

Sector

Industrials

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.80

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
AURA
Founded
1927
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.4M
797.5M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
NX
AURA
Price
$19.85
$7.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$28.00
$20.00
AVG Volume (30 Days)
287.5K
766.9K
Earning Date
06-04-2026
05-08-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
N/A
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$4.73
52 Week High
$22.90
$9.54

Technical Indicators

Market Signals
Indicator
NX
AURA
Relative Strength Index (RSI) 53.22 57.18
Support Level $15.52 $6.49
Resistance Level $21.72 $9.54
Average True Range (ATR) 0.73 0.48
MACD -0.20 0.00
Stochastic Oscillator 29.50 59.03

Price Performance

Historical Comparison
NX
AURA

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: